TrueParallel, Author at AskBio - Page 3 of 5

Selecta and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR in Gene Therapy Posted on February 17, 2021 (February 17, 2021) by TrueParallel in News
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy Posted on January 28, 2021 by TrueParallel in News
Gene Therapy Leader Katherine High Joins AskBio as President, Therapeutics Posted on January 12, 2021 (January 12, 2021) by TrueParallel in News
AskBio Applauds Commencement of Pfizer’s Pivotal Trial for Duchenne Muscular Dystrophy Posted on January 8, 2021 (January 27, 2021) by TrueParallel in News
AskBio Welcomes Brain Neurotherapy Bio to Expand Clinical Pipeline for Neurodegenerative Diseases Posted on December 16, 2020 (January 28, 2021) by TrueParallel in News
AskBio CSO Jude Samulski Named 2020 Business Person of the Year by Triangle Business Journal Posted on December 11, 2020 by TrueParallel in News
AskBio and Selecta Receive Orphan Drug Designation for MMA-101 to Treat Methylmalonic Acidemia Posted on November 19, 2020 (January 27, 2021) by TrueParallel in News
Bayer Acquires AskBio to Broaden Innovation Base in Cell and Gene Therapy Posted on October 26, 2020 (October 26, 2020) by TrueParallel in News
Selecta and AskBio Receive FDA Rare Pediatric Disease Designation for Methylmalonic Acidemia Gene Therapy Posted on October 20, 2020 (December 2, 2020) by TrueParallel in News
Kellie Sears Named AskBio Chief Human Resources Officer Posted on September 16, 2020 (September 16, 2020) by TrueParallel in News